All Stories

  1. Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing
  2. Unlocking the therapeutic potential of Nigella sativa extract: phytochemical analysis and revealing antimicrobial and antioxidant marvels
  3. Novel Quinoline-3,4-dihydropyrimidinone Hybrids Privileged Scaffolds: Design, Synthesis, and Cytotoxic Evaluation
  4. Review; Recent approaches on Tubulin Polymerization inhibitors (2018-2022)
  5. Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae
  6. Phenotypic, molecular, and in silico characterization of coumarin as carbapenemase inhibitor to fight carbapenem-resistant Klebsiella pneumoniae
  7. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model
  8. Insights on the therapeutic effect of quinolone-based compound, PPQ-8 plus Nitazoxanide in chronic toxoplasmosis murine model
  9. New Pyrazole-Clubbed Pyrimidine or Pyrazoline Hybrids as Anti-Methicillin-Resistant Staphylococcus aureus Agents: Design, Synthesis, In Vitro and In Vivo Evaluation, and Molecular Modeling Simulation
  10. Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation
  11. In vivo Anticonvulsant and Neurotoxicity Evaluation and Docking Study of Promising Novel [1,5]-Benzodiazepine Derivatives
  12. In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates
  13. Quantification of 16 cephalosporins in the aquatic environment by liquid chromatography‐tandem mass spectrometry
  14. Synthesis and Molecular Docking Study of New Thiazole Derivatives as Potential Tubulin Polymerization Inhibitors
  15. Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against Staphylococcus aureus: in vitro and in vivo studies
  16. In vitro cytotoxicity and docking study of novel symmetric and asymmetric dihydropyridines and pyridines as EGFR tyrosine kinase inhibitors
  17. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates
  18. In colorectal cancer; NMR-monitored β-Catenin inhibition by a Quinoline derivative using Water-LOGSY technique
  19. Virtual Screening Attributes Male Biased COVID-19 Mortality to Predicted Antiviral Activity of Female Sex Hormones
  20. Homology modelling, molecular dynamics simulation and docking evaluation of β-tubulin of Schistosoma mansoni
  21. Soil-Associated Bacillus Species: A Reservoir of Bioactive Compounds with Potential Therapeutic Activity against Human Pathogens
  22. The Link between Occurrence of Class I Integron and Acquired Aminoglycoside Resistance in Clinical MRSA Isolates
  23. Back to Nature: Combating Candida albicans Biofilm, Phospholipase and Hemolysin Using Plant Essential Oils
  24. Novel 2-(5-Aryl)thiophen-2-yl)benzimidazoles; Design, Synthesis and In vitro Evaluation Against Cercarial Phase of Schistosoma mansoni
  25. In vivo studies of the effect of PPQ-6, a quinoline-based agent against Schistosoma mansoni in mice
  26. Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B
  27. Effect of a newly synthesized quinoline-based compound (PPQ-8) on murine schistosomiasis mansoni
  28. Therapeutic efficacy of a newly synthesized benzimidazole compound BTP-OH against murine schistosomiasis mansoni
  29. In vitro efficacy of new synthetic benzimidazole-related compounds against Schistosoma mansoni adult worms
  30. Biological evaluation of newly synthesized quinoline–based compound PPQ-8 in acute and chronic toxoplasmosis: An experimental study
  31. Cytotoxicity and Molecular Targeting Study of Novel 2-Chloro-3- substituted Quinoline Derivatives as Antitumor Agents
  32. 2-Chloroquinoline-3-carbaldehydes: synthesis and reactions (2012-2017)
  33. In vitro screening of BTP-Iso on Schistosoma mansoni and its intermediate host Biomphalaria alexandrina
  34. Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection